All systems operational
For Researchers For Publishers Login Register
Home Authors AlFadel AlShaibani
AA

AlFadel AlShaibani

h-2 H-Index
105 Citations
4 Papers

Published Papers

4 indexed
1
The Risk and Prognosis of COVID-19 Infection in Cancer Patients
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.07.005
80 citations 396
2
Hepatitis-Associated Aplastic Anemia
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.10.001
24 citations 387
3
Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients
Annals of Saudi Medicine Q1 2024 10.5144/0256-4947.2024.93
1 citations 2,139
4
Familial Emberger Syndrome With Autoimmunity, Hyper-Immunoglobulin E and Lymphatic Impairment Caused by a Novel GATA2 Mutation
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.05.004
0 citations 391

Publication Activity

Journals Published In

Annals of Saudi Medicine
🇸🇦 Q1 AMS 90
Hematology/Oncology and Stem Cell Therapy
🇸🇦 Q3 AMS 72